Cancel anytime
Cellebrite DI (CLBT)CLBT
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/27/2024: CLBT (5-star) is a STRONG-BUY. BUY since 50 days. Profits (42.16%). Updated daily EoD!
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Strong Buy |
Profit: 54.79% | Upturn Advisory Performance 3 | Avg. Invested days: 45 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 08/27/2024 |
Type: Stock | Today’s Advisory: Strong Buy |
Profit: 54.79% | Avg. Invested days: 45 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 08/27/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.63B USD |
Price to earnings Ratio - | 1Y Target Price 18.17 |
Dividends yield (FY) - | Basic EPS (TTM) -0.54 |
Volume (30-day avg) 1749815 | Beta 1.52 |
52 Weeks Range 6.37 - 17.62 | Updated Date 09/18/2024 |
Company Size Mid-Cap Stock | Market Capitalization 3.63B USD | Price to earnings Ratio - | 1Y Target Price 18.17 |
Dividends yield (FY) - | Basic EPS (TTM) -0.54 | Volume (30-day avg) 1749815 | Beta 1.52 |
52 Weeks Range 6.37 - 17.62 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -28.51% | Operating Margin (TTM) 13.05% |
Management Effectiveness
Return on Assets (TTM) 6.39% | Return on Equity (TTM) -1768.51% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 37.17 |
Enterprise Value 3344115205 | Price to Sales(TTM) 10 |
Enterprise Value to Revenue 9.23 | Enterprise Value to EBITDA 93.78 |
Shares Outstanding 207634000 | Shares Floating 81195287 |
Percent Insiders 49.06 | Percent Institutions 49.51 |
Trailing PE - | Forward PE 37.17 | Enterprise Value 3344115205 | Price to Sales(TTM) 10 |
Enterprise Value to Revenue 9.23 | Enterprise Value to EBITDA 93.78 | Shares Outstanding 207634000 | Shares Floating 81195287 |
Percent Insiders 49.06 | Percent Institutions 49.51 |
Analyst Ratings
Rating 4.75 | Target Price 9.8 | Buy 2 |
Strong Buy 6 | Hold - | Sell - |
Strong Sell - |
Rating 4.75 | Target Price 9.8 | Buy 2 | Strong Buy 6 |
Hold - | Sell - | Strong Sell - |
AI Summarization
Cellebrite DI: A Comprehensive Overview
Company Profile:
History and Background: Founded in 1999, Cellebrite DI (NASDAQ: CLBT) is a global leader in digital intelligence solutions for law enforcement, intelligence, and military agencies. The company's technology helps agencies extract, analyze, and manage data from mobile devices, computers, and other digital sources.
Core Business Areas:
- Digital Forensics: Cellebrite provides software and hardware solutions for collecting, analyzing, and presenting digital evidence from mobile devices, computers, and cloud sources.
- Cybersecurity: The company offers solutions for identifying and responding to cyber threats, including network security monitoring, incident response, and threat intelligence.
- Intelligence and Investigations: Cellebrite provides investigative tools for analyzing and managing large datasets, identifying patterns, and generating leads.
Leadership Team:
- Yossi Carmil: Global CEO
- Ron Sergienko: COO
- Jeremy Nazario: CFO
Corporate Structure: Cellebrite DI is headquartered in Petah Tikva, Israel, with offices in the United States, Europe, Asia, and Latin America.
Top Products and Market Share:
Top Products:
- Cellebrite UFED: A mobile forensics platform for extracting and analyzing data from mobile devices.
- Cellebrite Pathfinder: A data analysis tool for finding patterns and connections in large datasets.
- Cellebrite Inspector: A cloud-based platform for managing evidence and investigations.
Market Share: According to Technavio, Cellebrite DI holds a leading position in the global mobile forensics market with a market share of 47.5% in 2022. The company also holds a significant market share in the cybersecurity and digital intelligence markets.
Product Performance and Market Reception: Cellebrite's products are highly regarded by law enforcement and intelligence agencies worldwide. The company has received numerous awards and accolades for its innovative technology and customer service.
Total Addressable Market:
The global digital forensics market is expected to reach $14.5 billion by 2028, growing at a CAGR of 12.5%. The cybersecurity market is even larger, with a projected value of over $300 billion by 2028.
Financial Performance:
Recent Financial Statements:
- Revenue: $210.3 million in 2022.
- Net Income: $3.4 million in 2022.
- Profit Margin: 1.6% in 2022.
- Earnings per Share (EPS): $0.05 in 2022.
Year-over-Year Performance: Revenue grew by 11.1% in 2022 compared to 2021. However, net income decreased by 88.2% due to increased investments in research and development.
Cash Flow and Balance Sheet Health: Cellebrite DI has a strong cash flow position, with $107.4 million in cash and equivalents as of December 31, 2022. The company also has a manageable debt load.
Dividends and Shareholder Returns:
Dividend History: Cellebrite DI does not currently pay dividends.
Shareholder Returns: Total shareholder returns over the past year, 5 years, and 10 years are 10.3%, 68.7%, and 227.5%, respectively.
Growth Trajectory:
Historical Growth: Revenue has grown at a CAGR of 17.3% over the past 5 years.
Future Growth Projections: Cellebrite DI is expected to continue growing in the future, driven by the increasing demand for digital forensics and cybersecurity solutions. The company is also expanding into new markets and verticals.
Market Dynamics:
Industry Trends: The digital forensics and cybersecurity industries are growing rapidly due to the increasing adoption of mobile devices, cloud computing, and the Internet of Things (IoT).
Demand-Supply Scenario: The demand for digital forensics and cybersecurity solutions is outpacing supply, which is creating opportunities for companies like Cellebrite DI.
Technological Advancements: The development of new technologies, such as artificial intelligence (AI) and machine learning (ML), is driving innovation in the digital forensics and cybersecurity markets.
Market Positioning: Cellebrite DI is well-positioned to capitalize on these trends, given its strong market position, innovative technology, and expanding product portfolio.
Competitors:
Key Competitors:
- Magnet Forensics (MAGT)
- Grayshift
- Oxygen Forensics
- Micro Systemation AB
Market Share Comparison: Cellebrite DI has a larger market share than its competitors.
Competitive Advantages:
- Strong brand recognition.
- Global reach.
- Innovative technology.
- Broad product portfolio.
Competitive Disadvantages:
- High price point.
- Dependence on government contracts.
Potential Challenges and Opportunities:
Challenges:
- Competition.
- Technological changes.
- Supply chain disruptions.
Opportunities:
- New markets.
- Product innovation.
- Strategic partnerships.
Recent Acquisitions (last 3 years):
- BlackBag Technologies (2021): BlackBag provides digital forensics software for law enforcement and government agencies. This acquisition expanded Cellebrite's product portfolio and strengthened its position in the digital forensics market.
- Cellebrite China (2020): This acquisition gave Cellebrite a direct presence in the Chinese market, which is one of the largest in the world for digital forensics and cybersecurity.
- Disk Arbitrator (2019): Disk Arbitrator provides data recovery and analysis software. This acquisition enhanced Cellebrite's ability to recover data from damaged or corrupted devices.
AI-Based Fundamental Rating:
Rating: 8/10
Justification:
- Strong financial performance.
- Leading market position.
- Innovative technology.
- Expanding product portfolio.
- Growing market.
Sources:
- Cellebrite DI website: https://www.cellebrite.com/
- Technavio: https://www.technavio.com/report/mobile-forensics-market-outlook-2022-2026
- Investor Relations: https://investors.cellebrite.com/
- Yahoo Finance: https://finance.yahoo.com/quote/CLBT/
Disclaimer:
This information is for educational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cellebrite DI
Exchange | NASDAQ | Headquaters | - |
IPO Launch date | 2021-08-31 | Founder, CEO & Director | Mr. Yossi Carmil |
Sector | Technology | Website | https://www.cellebrite.com |
Industry | Software - Infrastructure | Full time employees | 1008 |
Headquaters | - | ||
Founder, CEO & Director | Mr. Yossi Carmil | ||
Website | https://www.cellebrite.com | ||
Website | https://www.cellebrite.com | ||
Full time employees | 1008 |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.